Xlife Sciences AG, CH0461929603

Xlife Sciences AG, CH0461929603

23.01.2023 - 07:06:18

Stifel initiates research coverage of Xlife Sciences

Xlife Sciences AG,? Talacker 35,? 8001 Zurich,? Switzerland, Phone +41 44 385 84 60info@xlifesciences.ch, www.xlifesciences.ch,? Commercial Register Zurich CHE-330.279.788? Stock Exchange: SIX Swiss Exchange

About Xlife Sciences AG (SIX: XLS)? Xlife Sciences is a Swiss company focused as incubator and accelerator on the value development and commercialization of promising research projects from universities and other research institutions in the life sciences sector, with the aim of providing solutions for high unmet medical needs and a better quality of life. The goal is to bridge research and development to healthcare markets. Xlife Sciences takes carefully selected projects in the four areas of technological platforms, biotechnology/ therapies, medical technology, and artificial intelligence/digital health to the next stage of development, and participates in their subsequent performance. For more information, visit www.xlifesciences.ch?

Disclaimer? Some of the information contained in this media release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Xlife Sciences undertakes no obligation to publicly update or revise any forward-looking statements.?

End of Media Release

Language: English Company: Xlife Sciences AG Talacker 35 8001 Z?rich

Switzerland Phone: +41 44 385 84 60 E-mail: info@xlifesciences.ch Internet: www.xlifesciences.ch ISIN: CH0461929603 Valor: A2PK6Z Listed: SIX Swiss Exchange EQS News ID: 1540625 ? End of News EQS News Service


@ dgap.de